Dr. Jim Musser Becomes President of FASEB

James M. Musser, M.D., Ph.D., assumed the role of President of the Federation of American Societies for Experimental Biology ( FASEB ) on July 1, 2018. Dr. Musser succeeds Dr. Thomas O. Baldwin who served in this role from July 2017 to June 2018. Dr. Musser is a Past-President of the American Society for Investigative Pathology ( ASIP ), serving in this role in 2013. FASEB was founded in 1912 and now represents 30 scientific societies and over 130,000 researchers world-wide. FASEB is recognized as the research and science policy voice of biological and biomedical researchers. Dr. Musser is the 26 th ASIP member to serve as FASEB President.

Dr. Musser is Chair of the Department of Pathology and Genomic Medicine of the Houston Methodist Hospital System and Research Institute in Houston. He holds the Fondren Endowed Presidential Distinguished Chair and is the Director of the Center for Molecular and Translational Human Infectious Diseases Research at the Houston Methodist Hospital Research Institute. Dr. Musser is a long-time member of the ASIP (since 1992). In addition to being a Past-President of the ASIP , Dr. Musser has served on the ASIP Council and as the ASIP representative to the FASEB Board of Directors for many years. Dr. Musser has been honored by the ASIP with several awards, including the ASIP Warner-Lambert/Parke-Davis Award in 1999 (now called the ASIP Outstanding Investigator Award), the ASIP Chugai Award for Excellence in Mentoring and Scholarship in 2007, and the ASIP Rous-Whipple Award in 2017.